Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis.
about
Laparoscopic versus open transhiatal oesophagectomy for oesophageal cancerNon-surgical versus surgical treatment for oesophageal cancerChemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancerPerioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagusWeekday of oesophageal cancer surgery in relation to early postoperative outcomes in a nationwide Swedish cohort studyBarrett's esophagus in 2016: From pathophysiology to treatmentEmerging therapeutic targets in esophageal adenocarcinomaSurvival rate of gastric cancer in Iran; a systematic review and meta-analysisPerioperative and Palliative Chemotherapy for Esophageal CancerLymphatic spreading and lymphadenectomy for esophageal carcinomaPredicting the Response of Neoadjuvant Therapy for Patients with Esophageal Carcinoma: an In-depth Literature ReviewSystematic review and network meta-analysis: neoadjuvant chemoradiotherapy for locoregional esophageal cancerWhat to publishMultimodal treatment of gastric cancer in the west: Where are we going?Treatment of esophagogastric junction carcinoma: an unsolved debateThe role of induction therapyRecent developments in esophageal adenocarcinomaClinical management of gastroesophageal junction tumors: past and recent evidences for the role of radiotherapy in the multidisciplinary approachThe value of [18F]fluorodeoxyglucose-PET/CT in oesophageal cancerNeoadjuvant Therapy of Gastric Cancer: A Decisive Step ForwardRadiation therapy and esophageal cancerThe epidemiology, diagnosis, and treatment of Barrett's carcinomaCorrelation of p53 status with the response to chemotherapy-based treatment in esophageal cancer: a meta-analysis.Long noncoding RNAs are novel potential prognostic biomarkers for esophageal squamous cell carcinoma: an overviewPreoperative therapy in locally advanced esophageal cancerReevaluation of Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma: A Meta-Analysis of Randomized Controlled Trials Over the Past 20 YearsLocally advanced gastroesophageal junction tumor: a treatment dilemmaNeoadjuvant treatment for advanced esophageal cancer: response assessment before surgery and how to predict response to chemoradiation before starting treatmentThe Synthetic β-Nitrostyrene Derivative CYT-Rx20 Inhibits Esophageal Tumor Growth and Metastasis via PI3K/AKT and STAT3 PathwaysWestern strategy for EGJ carcinoma.Current Status and Future Prospects for Esophageal Cancer TreatmentCurrent Advancement in Multidisciplinary Treatment for Resectable cStage II/III Esophageal Squamous Cell Carcinoma in Japan.Comparison of neoadjuvant versus a surgery first approach for gastric and esophagogastric cancer.Effects on heart function of neoadjuvant chemotherapy and chemoradiotherapy in patients with cancer in the esophagus or gastroesophageal junction - a prospective cohort pilot study within a randomized clinical trial.High-Grade Toxicity to Neoadjuvant Treatment for Upper Gastrointestinal Carcinomas: What is the Impact on Perioperative and Oncologic Outcomes?Concurrent Neoadjuvant Chemoradiotherapy for Siewert II and III Adenocarcinoma at Gastroesophageal JunctionRecent advances in preoperative management of esophageal adenocarcinomaThe prognostic effect of perineural invasion in esophageal squamous cell carcinomaHigh dose radiation with chemotherapy followed by salvage esophagectomy among patients with locally advanced esophageal squamous cell carcinoma.Computed tomography (CT) perfusion as an early predictive marker for treatment response to neoadjuvant chemotherapy in gastroesophageal junction cancer and gastric cancer--a prospective study.
P2860
Q24185993-469EED6A-5B37-4ECB-8764-0BF4DD879FBBQ24186005-9ABCCF72-F203-45C0-9ECA-A2932F6CBA92Q24197524-7A71B30D-BFCA-4CC0-A57C-D3006905D7D5Q24202957-E4D2466D-0AC1-4009-9F83-0EEA52D4AD89Q24658539-B0F37F87-8D0B-477F-A6E8-6E31CFCEB56BQ26751171-1B01F00B-CB8F-4549-AA2A-5ADD7CA4BDF4Q26751209-7DB80565-1766-46F1-9666-28BA1F4FA6E8Q26751297-31797C27-8731-4BF4-B8DA-B787678E1D4EQ26753865-86E09220-D6DF-4383-979C-9F3927F27544Q26769064-0467E82A-04A3-4D9A-96F4-F5AA7CBAA988Q26777898-460E8508-14FB-4129-AC78-0364E1AB6074Q26798301-5D6043C0-C748-48D9-AA1D-FDAC050B4714Q26799288-F327929B-5717-4590-9001-44C29AE8B433Q26799748-7454A5C7-702A-45C4-8351-14B3CE783C3CQ26827179-42AB2190-6AD0-4D46-B43B-CEE1CA1333B5Q26830698-7782BE6D-14F9-48F5-9FFA-E31746877C53Q26849652-50092067-FB37-4DEB-A88C-7D510931E49CQ26862365-21794990-49EE-462D-A589-F8801BE54730Q26864611-69D86EA7-DDC1-4280-BE33-6C9A1E41D655Q27016030-976282B0-6030-4ACD-B196-6028EA6F31F5Q27026922-9990AA10-AC41-4B86-B1C1-F35B80AA6122Q27027149-00B3FC65-B8C9-463B-A4EF-9CC884BB2EDFQ27852124-F793779D-09D1-4328-8DD0-2994348F97AEQ28069216-A03A5B64-BAD2-444D-A286-F411EF174B44Q28070310-EE93FEF2-3967-4A54-929B-B78F0B329FFDQ28081365-C40F047E-1C13-49E0-9970-FA1852EC6AD8Q28082596-DD6450BC-E204-4F2F-B90D-D04262A50754Q28086781-E50CABE2-0592-447A-9109-31D1D5D4FC5EQ28553655-7C2F87E4-7355-4720-8059-0173E4F1774AQ30239851-B5DDA7DD-0785-4E4A-AB86-0911A0BF4E23Q30240008-1B22463A-5414-487A-8D1D-F25AE368AACCQ30244382-48BF401A-41F0-4B0F-B012-E0C725AB1AD9Q30248541-3E67157E-20A5-4AAC-B74B-D93BB32AE56FQ30418495-7CA55FA9-D12F-4711-9CA0-9F9C7FAC1CDDQ33420370-92681120-C90F-442F-9142-4FA22FAC43CBQ33422992-E21BFCDF-FD5D-41CB-BDDC-877228AB57FCQ33589301-EB5AC284-949D-448A-8CB6-932232968058Q33593057-B7745CC7-422E-4CBB-9972-DF7FCE2BA822Q33633596-4238361A-0A71-4839-A28D-BAD87B81CE9FQ33638337-B59DE144-0E73-4CFD-B261-8445EEB5C93A
P2860
Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Survival after neoadjuvant che ...... oma: an updated meta-analysis.
@en
Survival after neoadjuvant che ...... oma: an updated meta-analysis.
@nl
type
label
Survival after neoadjuvant che ...... oma: an updated meta-analysis.
@en
Survival after neoadjuvant che ...... oma: an updated meta-analysis.
@nl
prefLabel
Survival after neoadjuvant che ...... oma: an updated meta-analysis.
@en
Survival after neoadjuvant che ...... oma: an updated meta-analysis.
@nl
P2093
P921
P1433
P1476
Survival after neoadjuvant che ...... noma: an updated meta-analysis
@en
P2093
Andrew Barbour
Australasian Gastro-Intestinal Trials Group
Bryan H Burmeister
John R Zalcberg
R John Simes
Val Gebski
P304
P356
10.1016/S1470-2045(11)70142-5
P577
2011-06-16T00:00:00Z